These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37981465)

  • 1. The role of sex hormones, oral contraceptive use, and its parameters on visuospatial abilities, verbal fluency, and verbal memory.
    Davignon LM; Brouillard A; Juster RP; Marin MF
    Horm Behav; 2024 Jan; 157():105454. PubMed ID: 37981465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives and cognition: A role for ethinyl estradiol.
    Beltz AM; Hampson E; Berenbaum SA
    Horm Behav; 2015 Aug; 74():209-17. PubMed ID: 26122296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of menstrual cycle phase and oral contraceptive use on verbal memory.
    Mordecai KL; Rubin LH; Maki PM
    Horm Behav; 2008 Aug; 54(2):286-93. PubMed ID: 18455727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duration of oral contraceptive use relates to cognitive performance and brain activation in current and past users.
    Noachtar IA; Hidalgo-Lopez E; Pletzer B
    Front Endocrinol (Lausanne); 2022; 13():885617. PubMed ID: 36204097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of hormonal contraceptives on mental rotation and verbal fluency.
    Griksiene R; Ruksenas O
    Psychoneuroendocrinology; 2011 Sep; 36(8):1239-48. PubMed ID: 21454017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of oral contraceptives on spatial cognition depend on pharmacological properties and phase of the contraceptive cycle.
    Hampson E; Morley EE; Evans KL; Fleury C
    Front Endocrinol (Lausanne); 2022; 13():888510. PubMed ID: 36147581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic alterations of the fear circuitry: the role of sex hormones and oral contraceptives.
    Brouillard A; Davignon LM; Turcotte AM; Marin MF
    Front Endocrinol (Lausanne); 2023; 14():1228504. PubMed ID: 38027091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of action of a new low-dosed combined oral contraceptive.
    Dericks-Tan JS; Schneider K; Taubert HD
    Arch Gynecol; 1980; 229(2):107-14. PubMed ID: 6768343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex difference or hormonal difference in mental rotation? The influence of ovarian milieu.
    Peragine D; Simeon-Spezzaferro C; Brown A; Gervais NJ; Hampson E; Einstein G
    Psychoneuroendocrinology; 2020 May; 115():104488. PubMed ID: 31899008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mental rotation, episodic memory, and executive control: Possible effects of biological sex and oral contraceptive use.
    Jensen A; Thériault K; Yilmaz E; Pon E; Davidson PSR
    Neurobiol Learn Mem; 2023 Feb; 198():107720. PubMed ID: 36621560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian function is effectively inhibited by a low-dose triphasic oral contraceptive containing ethinylestradiol and levonorgestrel.
    Gaspard UJ; Dubois M; Gillain D; Franchimont P; Duvivier J
    Contraception; 1984 Apr; 29(4):305-18. PubMed ID: 6430638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Oral Contraceptive Androgenicity on Visuospatial and Social-Emotional Cognition: A Prospective Observational Trial.
    Gurvich C; Warren AM; Worsley R; Hudaib AR; Thomas N; Kulkarni J
    Brain Sci; 2020 Mar; 10(4):. PubMed ID: 32218215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS
    Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives.
    Aden U; Jung-Hoffmann C; Kuhl H
    Contraception; 1998 Aug; 58(2):75-81. PubMed ID: 9773261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative contraceptive efficacy and mechanism of action of the norgestimate-containing triphasic oral contraceptive.
    London RS; Chapdelaine A; Upmalis D; Olson W; Smith J
    Acta Obstet Gynecol Scand Suppl; 1992; 156():9-14. PubMed ID: 1324557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
    Akerlund M; Almström E; Högstedt S; Nabrink M
    Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary and ovarian function in women receiving hormonal contraception.
    Cohen BL; Katz M
    Contraception; 1979 Nov; 20(5):475-87. PubMed ID: 393456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal treatment for bleeding irregularities in Norplant implant users.
    Alvarez-Sanchez F; Brache V; Thevenin F; Cochon L; Faundes A
    Am J Obstet Gynecol; 1996 Mar; 174(3):919-22. PubMed ID: 8633669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex hormone binding globulin: effect of synthetic steroids on the assay and effect of oral contraceptives.
    Bowles SM; Mills RJ
    Ann Clin Biochem; 1981 Jul; 18(Pt 4):226-31. PubMed ID: 7197136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.